EphA3 Antibodies

Santa Cruz Biotechnology provides a broad selection of EphA3 monoclonal antibodies for research focused on understanding EphA3 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphA3 is a member of the Eph receptor family, which plays a significant role in cell signaling and communication. EphA3 actively participates in cell adhesion, migration, and tissue organization processes, making it essential for normal development and function. Research has shown that EphA3 dysregulation is associated with various diseases, including cancer, highlighting its significance as a potential therapeutic target. Understanding EphA3's molecular mechanisms and signaling pathways can provide valuable insights into disease progression and treatment strategies. Investigating EphA3's role in cellular processes requires reliable and specific detection methods. Advanced research techniques and protocols help unlock new discoveries about EphA3's biological functions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EphA3's role in health and disease.